Consequently, the CD8a/FoxP3 ratio was elevated in Axl KO tumors, although this was only statistically significant in MOC2-398, indicating a shift towards a more anti-tumor immune profile (Figure 3F). The gene discussed is AXL; the disease is neoplasm.